NCT02214901View on ClinicalTrials.gov

Safety, Tolerability and Pharmacokinetics of BIBW 2948 BS in Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

91

Participants

Timeline

Start Date

March 31, 2005

Primary Completion Date

July 31, 2005

Conditions
Healthy
Interventions
DRUG

BIBW 2948 BS for oral inhalation

DRUG

Placebo

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY